Bookbot

Drugs and the Pharmaceutical Sciences - 175: Protein Formulation and Delivery

Second Edition

Parámetros

  • 376 páginas
  • 14 horas de lectura

Más información sobre el libro

This title is intended to assist pharmaceutical scientists in the development of stable protein formulations during the early stages of the product development process, providing a comprehensive review of mechanisms and causes of protein instability in formulation development, coverage of accelerated stability testing methods and relevant analytical methods, and an overview of the drug substance manufacturing process. Preformulation and the development of traditional solutions and lyophilized formulations frequently used for intravenous delivery and non-traditional formulations are also addressed. Because many developments in the field have emerged since the publication of the First Edition, this Second Edition addresses important new patient-friendly developments in the field, such as formulation for implantable devices, needle-free formulation and delivery approaches, and oral delivery of proteins.

Compra de libros

Drugs and the Pharmaceutical Sciences - 175: Protein Formulation and Delivery, Eugene J. McNally, Jayne E. Hastedt

Idioma
Publicado en
2007
product-detail.submit-box.info.binding
(Tapa dura),
Estado del libro
Muy Bueno
Precio
45,99 €

Métodos de pago

Nadie lo ha calificado todavía.Añadir reseña

Título
Drugs and the Pharmaceutical Sciences - 175: Protein Formulation and Delivery
Subtítulo
Second Edition
Idioma
Inglés
Editorial
CRC Press
Publicado en
2007
Formato
Tapa dura
Páginas
376
ISBN10
0849379490
ISBN13
9780849379499
Serie
Descripción
This title is intended to assist pharmaceutical scientists in the development of stable protein formulations during the early stages of the product development process, providing a comprehensive review of mechanisms and causes of protein instability in formulation development, coverage of accelerated stability testing methods and relevant analytical methods, and an overview of the drug substance manufacturing process. Preformulation and the development of traditional solutions and lyophilized formulations frequently used for intravenous delivery and non-traditional formulations are also addressed. Because many developments in the field have emerged since the publication of the First Edition, this Second Edition addresses important new patient-friendly developments in the field, such as formulation for implantable devices, needle-free formulation and delivery approaches, and oral delivery of proteins.